Parathyroid cancer is a very rare type of cancer that starts in the parathyroid gland. It can cause hyperparathyroidism, which can result in high calcium levels in the blood. The most common treatment ...

Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown. New ...

Please provide your email address to receive an email when new articles are posted on . A 49-year-old woman presented with hypercalcemia. She had been experiencing weight loss, polyuria, nocturia, ...

A pair of clinical guidelines on hypo- and hyperparathyroidism, respectively, had a coming-out party at the American Society for Bone and Mineral Research's (ASBMR) annual meeting on Sunday, allowing ...

Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed ...

Since the use of parathyroid hormone as a treatment for osteoporosis is limited to two years or less, the question of whether antiresorptive therapy should follow parathyroid hormone therapy is ...

Please provide your email address to receive an email when new articles are posted on . The researchers conducted a prospective, population-based, longitudinal cohort study of women from the Malmö ...

A parathyroid adenoma is a benign tumor on one of your parathyroid glands. These are four very small glands located near or at the back of your thyroid gland. They produce parathyroid hormone (PTH).

Hypoparathyroidism happens when the parathyroid glands don’t make enough parathyroid hormone (PTH). This causes low calcium and high phosphorus levels that need lifelong monitoring. Low calcium can ...

At University of Utah Health, our endocrinologists have extensive experience in treating thyroid and parathyroid disorders. Our experts specialize in treatments that aren't widely available. Our ...

This is part of a brand-new Thread, kicked off for this reason: As I mentioned in yesterday’s Note, I’m not in a position to do follow-up reporting on a topic I mentioned after Garry Shandling’s death ...